Variation in market access decisions for cell and gene therapies across the United States, Canada, and Europe
Read more and download the article
Health Policy 2021; 125(12): 1550-1556
DOI: https://doi.org/10.1016/j.healthpol.2021.10.003
Our latest publications
Publication / Costs and disease burden
Modelling the wider socio-economic costs of opioid dependence in the UK
Publication / Policy
Genomic Medicine Sweden: Advancing precision medicine at the national level
Publication / Policy